Literature DB >> 3159448

Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover.

M Köhler, P Hellstern, E Morgenstern, C Mueller-Eckhardt, R Berberich, R J Meiser, P Scheffler, E Wenzel.   

Abstract

Clinical and laboratory studies of two siblings, both suffering from gray platelet syndrome (GPS) are described. The patients had a mild bleeding disorder, their platelets were blue-gray in panoptic stains, and alpha-granules were markedly reduced, as shown by electron microscopy. The platelet content of platelet factor 4 and that of beta-thromboglobulin were significantly reduced (3%-7% of normal). Platelet count was decreased (33-150 X 10(9)/1) and small platelets were increased in platelet volume distribution. Bleeding time was prolonged on most occasions. Bone marrow aspiration was performed in one patient and revealed increased reticulin fibers, however, megakaryocyte count was normal. The mean platelet survival was 4.8 days using 111indium-labelled platelets. In this patient, platelet-associated IgG was within the normal range. Prednisone therapy failed to increase platelet count. Dental surgery was performed under cover of desmopressin and no bleeding complication occurred; however, no improvement of bleeding time was observed. The patient delivered a healthy male infant without hemorrhaging while under concurrent platelet transfusion therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159448     DOI: 10.1007/bf00320926

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

Review 1.  Ultrastructural features of abnormal blood platelets. A review.

Authors:  J G White; J M Gerrard
Journal:  Am J Pathol       Date:  1976-06       Impact factor: 4.307

2.  Studies on the platelet radioactive anti-immunoglobulin test.

Authors:  C Mueller-Eckhardt; G Schulz; K H Sauer; C Dienst; I Mahn
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival.

Authors:  H J Reimers; M A Packham; R L Kinlough-Rathbone; J F Mustard
Journal:  Br J Haematol       Date:  1973-11       Impact factor: 6.998

4.  Platelet alpha granules contain a growth factor for fibroblasts.

Authors:  D R Kaplan; F C Chao; C D Stiles; H N Antoniades; C D Scher
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

5.  Gray platelet syndrome. A variety of qualitative platelet disorder.

Authors:  G Raccuglia
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

6.  Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.

Authors:  J Breton-Gorius; W Vainchenker; A Nurden; S Levy-Toledano; J Caen
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

7.  [Hereditary hypogranular thrombocytopathic thrombocytopenia. Ultrastructural study of a megakaryocytopathy (author's transl)].

Authors:  J Libánská; L Falcão; A Gautier; J Ammon; A Spahr; H Vainer; J Caen
Journal:  Nouv Rev Fr Hematol       Date:  1975 Mar-Apr

Review 8.  Molecular defects in interactions of platelets with the vessel wall.

Authors:  J N George; A T Nurden; D R Phillips
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

Review 9.  Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.

Authors:  H Castro-Malaspina; M A Moore
Journal:  Nouv Rev Fr Hematol       Date:  1982

10.  Platelet alpha granule depletion: findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery.

Authors:  C W Pumphrey; J Dawes
Journal:  Thromb Res       Date:  1983-05-01       Impact factor: 3.944

View more
  7 in total

1.  Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface.

Authors:  J P Rosa; J N George; D F Bainton; A T Nurden; J P Caen; R P McEver
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 2.  Inherited Macrothrombocytopenia: Correlating Morphology, Epidemiology, Molecular Pathology and Clinical Features.

Authors:  Kanjaksha Ghosh; Maitreyee Bhattacharya; Ranjini Chowdhury; Kanchan Mishra; Malay Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2018-05-05       Impact factor: 0.900

3.  Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.

Authors:  Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

4.  Platelets of the Wistar Furth rat have reduced levels of alpha-granule proteins. An animal model resembling gray platelet syndrome.

Authors:  C W Jackson; N K Hutson; S A Steward; N Saito; E M Cramer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.

Authors:  J Gebrane-Younès; E M Cramer; L Orcel; J P Caen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  The origin of the membrane convolute in degranulating platelets. A comparative study of normal and "gray" platelets.

Authors:  E Morgenstern; H Patscheke; G Mathieu
Journal:  Blut       Date:  1990-01

Review 7.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.